Researchers at the Biomedical Graduate Program and the Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA, have published a systematic review on serious adverse events… Read More »A systematic review of retinal gene therapy on the impact of route administrations and on serious adverse events (SAEs).
Researchers at the Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York, have published a study outlining how fundus autofluorescence (FAF)… Read More »A review of fundus autofluorescence (FAF) underscores an indispensable technology for the diagnosis, monitoring and outcome measures of numerous retinal diseases.
Clinical researchers at the Institute of Ophthalmology, University College London, UK, and Moorfields Eye Hospital NHS Foundation Trust, London, have presented a novel deep learning… Read More »Clinical study of >3,500 IRD patients reports novel genotype-phenotype associations using optical coherence tomography (OCT) imaging.
Researchers in Canada, have reported the first quantitative choroidal assessment in a cohort of patients with genetically characterized retinitis pigmentosa (RP). The results of the… Read More »First quantitative choroidal assessment may be valuable for using other standard metrics for retinal clinical trial evaluations.
Economic estimates have indicated that 2.25 billion coffees are consumed every day – this is a significant number. Researchers at the Department of Ophthalmology, Hubei… Read More »Anyone for a coffee – instant coffee may increase the risk of AMD, and reducing instant coffee intake can prevent dry AMD.
An independent study, funded by the Swedish government, has reported that intravitreal injections of anti-VEGF treatments were associated with a 2.9% risk for stroke among… Read More »Swedish clinical study reports a 3% increased risk of stroke within 90 days of anti-VEGF treatments.
A Phase 3 randomised clinical trial has recruited of >400 patients in a seven-month period, driven by clinical and patient interest, according to the trial’s… Read More »Phase 3 trial of vorolanib intravitreal insert, using a tyrosine kinase inhibitor (TKI), will be evaluating for wet age-related macular degeneration (wet AMD).
Clinical researchers at the Department of Ophthalmology and the Vision Centre of Excellence, Akron Children’s Hospital, Ohio, have reported a molecular diagnostic rate of 41.5%… Read More »Clinical research on patients with infantile nystagmus syndrome (INS), across several inherited ocular diseases, may provide significant support for counselling and on-going clinical trials.
Clinical researchers at the Sorbonne Université, INSERM, CNRS, Institut de la Vision and the Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, Paris, have reported PCARE-associated retinopathy… Read More »Natural history of PCARE-associated retinopathy highlights genetics, clinical characteristics and time-to-event curves for development of atrophy.
A consortium of clinical researchers and trial experts have launched a new updated statement published by 39 researchers*, led by Professor Sally Hopewell, based in… Read More »New “CONSORT 2025 statement” has announced an expanded checklist to optimally conduct high-quality research on randomised trials.
